Learn, Analyse & Invest
only with
only with
+91
Download Orca
Morepen Laboratories Ltd.
Morepen Laboratories
Morepen Laboratories Ltd. live price is ₹ 0.00. Price change 0.00, 0.00 percent.
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap - With a market cap of ₹68.82 Cr.
| EX-Date | Purpose |
|---|---|
| 28 04 2021 | Inter-alia, to consider and approve proposals for raising of funds, through one or more modes including further public offer/ right issue/ preferential issue of equity shares/ warrants/ fully or partly convertible instruments to public, investors, indian or foreign institution(s), body corporate including overseas corporate body(ies), NRI, foreign portfolio investor(s), promoters, promoter group and/or other entities, subject to such regulatory, statutory/ other approvals, as may be required. |
| 04 05 2021 | Audited Results |
| 27 07 2021 | Quarterly Results |
| 11 11 2021 | Quarterly Results |
| 08 02 2022 | Quarterly Results Inter alia, to consider and approve: (2) Variation/alteration of preference shareholders? rights, by converting said unlisted preference shares into Compulsorily Convertible Preference Shares and issuance of Equity Shares arising on conversion thereof, subject to the approval of preference shareholders, equity shareholders and such other regulatory, statutory authority(ies), as may be required. |
| 05 05 2022 | Audited Results |
| 29 07 2022 | Quarterly Results |
| 10 11 2022 | Quarterly Results |
| 13 02 2023 | Quarterly Results |
| 16 05 2023 | Audited Results |
| 05 08 2023 | Quarterly Results |
| 02 11 2023 | Quarterly Results |
| 31 01 2024 | Quarterly Results |
| 22 02 2024 | Inter alia, consider and approve the following matters: 1. To evaluate proposals for fund raising by the Company, by way of, inter-alia, issue of securities including equity shares or any other equity linked instruments or securities including nonconvertible debt instruments along with warrants and convertible securities other than warrants or any other eligible securities by way of, inter-alia, a preferential allotment or a private placement (including one or more qualified institutions placements or further public issue of equity, in accordance with the applicable provisions of the Companies Act, 2013 and its rules made thereunder and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, or through any other permissible mode, in such manner, and on such terms and conditions as may be deemed appropriate by the Board of Directors, including committee thereof, in its absolute discretion, subject to the receipt of necessary approvals, including the approval of the members of the Company at general meetings or through postal ballot and such other parties including regulatory and statutory approvals as may be required; 2. The notice of Extra-Ordinary General Meeting of the Company or Postal Ballot Notice along with explanatory statement thereto, inter-alia, for seeking approval of the members of the Company in relation to the above fund-raising proposal. |
| 11 11 2024 | Quarterly Results |
| 06 02 2025 | Quarterly Results |
| 12 05 2025 | Audited Results & Quarterly Results & Final Dividend |
| 06 08 2025 | Quarterly Results |
| 14 11 2025 | Quarterly Results |
| 10 02 2026 | Quarterly Results |
| 22 05 2026 | Audited Results & Quarterly Results |
| 26 05 2026 | Quarterly Results (Revised) & Final Dividend (Revised) & Audited Results |
| 04 08 2026 | Quarterly Results |